Tiziana life sciences announces resignation of ceo

New york, july 15, 2022 (globe newswire) -- tiziana life sciences ltd.(nasdaq: tlsa) (“tiziana” or the “company”), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug delivery, today announces that the board of directors has accepted the voluntary resignation of dr. kunwar shailubhai as chief executive officer, chief scientific officer and board director, effective as of august 1, 2022. dr. shailubhai resigned for personal reasons, and his resignation is not related to any disagreement with the company on any matter relating to the company's operations, policies or practices.
TLSA Ratings Summary
TLSA Quant Ranking